A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

Conditions:   Choroidal Melanoma;   Indeterminate Lesions;   Uveal Melanoma;   Ocular Melanoma Interventions:   Drug: Belzupacap Sarotalocan;   Device: Suprachoroidal Microinjector;   Device: Infrared Laser;   Device: Sham Infrared Laser;   Device: Sham Microinjector;   Drug: Sham Treatment Sponsor:   Aura Biosciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials